BioPharma Credit PLC (BOPCF)

Market Cap	1.10B +6.8%
Revenue (ttm)	131.40M -15.0%
Net Income	107.49M -12.7%
EPS	0.10 -9.1%
Shares Out	n/a
PE Ratio	10.25
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	99,452
Open	0.9262
Previous Close	0.9903
Day's Range	0.9262 - 0.9262
52-Week Range	0.8503 - 1.0200
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

• Industry: REIT - Residential
• Sector: Real Estate
• Founded: 2016
• Country: United Kingdom
• Stock Exchange: OTCMKTS
• Ticker Symbol: BOPCF

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error